new report, page-5

Overview:
SADIF Analytics releases new summary due diligence report for Admedus Ltd (AHZ)



2014-10-09 13:49:56 - SADIF-Investment Analytics has applied its StockMarksâ„¢ stock-rating system to Admedus Ltd (AHZ) and produced a report, rating the company's attractiveness to long-term investors.

Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due diligence report covering Admedus Ltd (AHZ). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential Admedus Ltd investor.

Report Summary: Admedus Ltd is a low quality company with a negative outlook. Admedus Ltd has strong business growth and is run by
inefficient management. The trend in Admedus Ltd fair value exchange rate against its closest rated-competitor, Medical Australia Limited, has been depreciating over the past 2 weeks. When compared to its closest competitor, Admedus Ltd shows similar overvaluation and is equally likely to underperform the market.

The report breaks down the Total StockMark into its three components - business, management and price, performing an in-depth analysis of Admedus Ltd for long-term investors.
The report has been distributed to Thomson Reuters, FactSet, CapitalIQ and Bloomberg {SADR }. Through Thomson Reuters is available in Investext and from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, One source West Services, and Dow Jones/Factiva.